Tanveer Yousaf, Sanipini Sailakshmn, Khleif Rafeef, Tsenteradze Tamar, Gapizov Abubakar, Grezenko Han, Affaf Maryam, Abdelaziz Ali M, Rehman Abdur, Zia Umar, Jama Huda, Shehryar Abdullah, Mohsin Syed Naveed, Ekhator Chukwuyem, Khan Rehman
Urology, Craigavon Area Hospital, Craigavon, GBR.
Medical School, Xavier University School of Medicine, Oranjestad, ABW.
Cureus. 2023 Oct 13;15(10):e46998. doi: 10.7759/cureus.46998. eCollection 2023 Oct.
This article provides an in-depth review of the current state of management for diabetes, hypertension, and cardiovascular disease, focusing on advancements from genomics to robotics. It explores the role of genomic markers in personalized medicine, offering tailored treatment options for these chronic conditions. The article also examines the efficacy of various pharmacological and surgical interventions, including bariatric surgery for diabetes and device-based treatments for hypertension. A comparative analysis is presented to evaluate the cost-effectiveness and patient outcomes between medical and surgical approaches. The review concludes that while personalized medicine and minimally invasive surgical techniques show promise, more high-quality comparative research is needed. The ultimate goal is to integrate these emerging technologies within a framework of evidence-based medicine to improve patient outcomes and health equity.
本文深入综述了糖尿病、高血压和心血管疾病的当前管理状况，重点关注从基因组学到机器人技术的进展。它探讨了基因组标记在个性化医疗中的作用，为这些慢性病提供量身定制的治疗方案。本文还研究了各种药物和手术干预措施的疗效，包括糖尿病的减肥手术和高血压的基于器械的治疗。进行了一项比较分析，以评估药物治疗和手术治疗方法之间的成本效益和患者预后。综述得出结论，虽然个性化医疗和微创外科技术显示出前景，但仍需要更多高质量的比较研究。最终目标是将这些新兴技术整合到循证医学框架内，以改善患者预后和健康公平性。
